Shortlink

Pharmacy News Online: Medical records go online at MidMichigan Health

Medical records go online at MidMichigan Health

The days of nurses coming to your bedside and flipping open your handwritten medical chart and doctors writing illegible prescriptions for tests and drugs are coming to an end at MidMichigan Medical Center Midland, and across the health system.

MERLIN, the internal name given to the electronic medical record project for MidMichigan Health, became operational Saturday at MidMichigan Medical Center Midland. Patients and guests to the hospital will notice greater quality of care and greater portability of their medical records.

A team of specialists from all four MidMichigan Health facilities in Midland, Gladwin, Clare and Alma have worked to install an electronic records system at the facilities during the past 19 months, according to Greg Rogers, president of MidMichigan Medical Center Midland and project co-sponsor.

It’s been six years since the medical facility began planning on changing to the new system and five years since the hospital installed SurgiNet, electronic records for the surgery unit.

“It’s been a long journey,” said Karen Calkins, who stayed on after retiring as the chief nursing officer to become a co-sponsor of the $50.1 million project with Rogers. Richard M. Reynolds, president of MidMichigan Health, is the executive sponsor of the EMR project.

Thousands of people at the four facilities have been involved.

“The whole health system has become the team, that’s how integrated we are,” said Sue Haley, the clinical project director.

The team began with 40 people, but as the months went by, experts from across the medical spectrum were brought in, according to Bob Harris, project technical director.

“Sometimes we’d have as many as 80 people working on the project,” he said.

The team has been working 12-hour days, six to seven days a week since October 2009. Haley said more than 398,000 man-hours, what she termed a conservative estimate, have been directed toward the project during that time, not counting the involvement of the Kansas City-based Cerner Corp., the vendor of the software, and Deloitte Consulting, both partners in the project.

“We look at this as a clinical transformation process. It’s about people and changing our processes and not just enabling IT software,” Calkins said. “We did a discovery phase and we spent a lot of time looking at current practices and worked with experts to determine what is best practice.

“Our guiding principles were about patient safety and quality and improving patient outcomes,” she said.

“Part of our mission is to improve the quality of life of the people in the communities we serve and it was a strategic focus for us to do this,” Rogers said. “This is a big step in that direction. This is the most complex project we’ve ever done at MidMichigan Health.”

Although Midland is the first facility in the organization to come on-line, all four facilities eventually will do away with the clinical charts and paper records which have been a part of hospitals and health care for as long as people can remember.

Harris said programs such as MERLIN, which stands for “multidisciplinary electronic record linking information across the network,” are becoming standard practice of care in the medical field.

“We are not on the tip of the spear. We’ve let other people spend a lot of R&D money to sort it out,” he said.

He said Cerner is one of the top two electronic medical record providers in the nation.

Rogers said, “Some people say the oldest system we have at the hospital is the system that we use to document. Some articles would suggest that that system is over 100 years old, and relatively unchanged. This is a quantum leap forward.”

At 10 p.m. Friday night, the hospital shut down all its old systems and began converting over to the new one. That task involved posting all the information on the old system to the new one, including discharging patients and readmitting them to the Cerner system, re-entering all patient prescriptions, checking all interfaces, and reentering all physician information.

A team of 34 people worked throughout the night Friday in the main command center, eight to 10 people were in the physician command center, eight people were working on interface coordination issues (making sure the different systems already in the hospital can talk to one another) and 14 people in the pharmacy group, the group with the greatest workload. All prescriptions will be entered by a pharmacist and checked by a nurse.

Although there is a lot of other work — including reregistering about 12,000 outpatients — Calkins said, “We’re very focused on maintaining the integrity of the (medication) orders as they cross from our current system to our live Cerner system, so that is where our focus has been.”

People are very excited, she said. “We’ve had a lot of volunteers. It’s not like we’ve had to twist people’s arms to do it.”

Patients will notice that information they give to hospital personnel will be entered into a computer system but it is what they might not even think about, or that they cannot see, that will be important to them.

For the most part, patients coming into the hospital will only have to provide information once, and that information will follow the patient from admitting, to ER, to surgery, to rehabilitation, to the pharmacy and to all the other places associated with the facility. In addition, the electronic record will keep track of chronic conditions, such as asthma or diabetes, that might affect prescription usage, compare prescribed medicines for compatibility and show hospital personnel a history of drug usage so that better decisions can be made.

Some questions might be re-asked to verify a person’s identification, but the basic information will be there, said Harris.

Haley said that having to give repeat answers to different members of a hospital team when patients are moved to different levels of care can irk some patients.

“Probably one of the most frustrating points that patients consistently speak about is the number of times they have to repeat information, so from the time a person has to see a physician with devastating diagnosis to the time that they come in for surgery, in a week’s time, in our current environment, pre-EMR, the same information as many as 15 times. Now, they will be giving that information once and it will then flow to the next caregiver. It will be a huge satisfied for our patients.”

Harris also noted dispensing medications will be safer under the new system. “Every medication we give will be bar coded, so we know what the drug is. Each patient will be bar coded and each caregiver will be bar coded.”

Then the medicine and patient will be scanned before each dose is administered and the nurse will get a confirmation that the medicine is “the correct drug, correct route, correct time, correct dose and correct patient.”

Doctors will be notified immediately if there is an error in dispensing medicines to one of their patients.

The EMR transition team has been working with a physician’s advisory group, headed by Dr. Pankaj Jandwani, which has been instrumental in making decisions involving the medical staff as well as in helping with the training.

“The physicians throughout MidMichigan Health have been outstanding,” Rogers noted.

Rogers pointed out two other improvements for both staff and patients. With written records, he noted, only one person at a time can look at a chart. All personnel taking care of a patient can look at the record electronically at the same time.

In addition, doctors can call up records from wherever they are, including at home, he said.

Hospital officials also addressed the security issue. Rogers said EMR are more secure than paper.

“Right now, who knows who is looking at the paper record. With this there is a trail of who has access.”

With the Cerner system, only people authorized by the hospital’s full-time security officer will be allowed access — at levels determined by the security individual — and the system is compliant with the federal Health Insurance Portability and Accountability Act.

“I can’t go in in my role and look at patient records … there’s no need for me,” Rogers said. “It’s more secure because you can control who has access.”

Harris said there are a lot of plug-ins and upgrades to the Cerner module that MidMichigan Health will be pursuing in the future. He also said Cerner, which is hosting program at its data site in Kansas City, has the redundancy needed for a hospital, which needs to be running all the time.

Penny Daniels, who was the EMR communications lead on the project, said meetings have been ongoing over the course of the project to ensure that employees had a chance to be heard, and to express their feelings about the change that was coming. And they’ve done some pretty creative things — such as the contest to name the transition MERLIN and working out of MidMichigan Medical Center Gratiot, where they were greeted warmly by the staff there.

Haley said that while the name served its purpose of helping to bring people from four units together during the long hours and long days, its now becoming the electronic medical records.”

“MERLIN is fading into the woodwork,” she said.

Harris said major suppliers of software for electronic medical records are working toward a continuity of care record that will allow cross platform transfer of medical information to different hospitals.

Rogers credited a lot of people for bringing the project on-line.

“The team has been outstanding,” he said.

Pharmacist shares his family’s triumphs, tragedies in novel

Dr. Luke A.M. Brown classifies his novel ‘The Non-Silence of the LAMB: Adult Contemporary Version’ (ISBN 1456588001) as a work of reality-fiction. While it is loosely based on certain dramatic events in his life, the book introduces readers to a Caribbean-American single mother’s immigration struggles and triumphs.

Essie, an orphan, has always dreamt of a better life. When she’s placed with a family in the Jamaican countryside, they treat her horribly and even resort to abusing her. She grows up to bear eight children without the assistance of the fathers to help raise them. She almost gives up hope until she decides to move to the United States, thus restoring her drive to live.

As Essie’s son, Brown draws upon his own life for the inspiration behind this novel. From a young age, the author admired his mother’s calm and confident demeanor and her will to plow ahead even when the large family had little to eat.

After losing his mother, two sisters and nephew within three years, Brown realized that many of his tragedies taught him some of life’s most important lessons. He was inspired to spread awareness of HIV and the severe consequences of the disease after losing his sister to it. Brown combines love, family feuds, success and heartbreak in ‘The Non-Silence of the LAMB’ to entertain adult readers.

‘The Non-Silence of the LAMB: Adult Contemporary Version’ is available for sale online at Amazon.comand other channels.

COLUMN: Patients play a key role in medication safety

Recently, health-care providers recognized National Patient Safety Awareness Week.

At Riverview Hospital Association, we strive to maintain a safe environment for our patients and community every day. Our physicians, nurses, pharmacists and technicians are members of each patient’s health care team and play a vital role ensuring that care is provided in a safe manner. Patients and families also have an important role to play in ensuring their own safety.

At Riverview Hospital, we provide our patients with “Partners in Safety” information, listing all of the things that a patient and his or her family can do to partner with us to provide safe care. While there are numerous things that are done to promote safety in the hospital and clinics, we would like to highlight one of the most important: Medication lists.

Patients play a key role in medication safety. Medication safety means that you will receive the medication prescribed to you at the right time and in the right way. Our physicians, nurses, pharmacists and technicians welcome your involvement. You can be a “Partner in Safety” by making a list of your current medications. The list should include the name of the medication, the dose and the frequency with which you take the medication. You should bring this list with you every time you seek medical care (physician’s office, pharmacy, emergency room and in the hospital).

When you seek medical care, the list will be reviewed with you, and the physician will determine which medications should be continued or discontinued. This is called “medication reconciliation.” Through medication reconciliation, you are being asked to learn about the medications you are taking, why and when you should take them and their potential side effects.

If you or a family member are unable to make a medication list, please bring all of your medications — including over-the-counter drugs, herbs, vitamins and other dietary supplements — in their original containers when you seek medical care. Your health care provider will assist you in making a medication list that you can carry with you.

Shortlink

Pharmacy News: High Street Pharmacies sell Viagra without Prescriptions

Investigators seek help with thefts at 3 Broward pharmacies

Investigators are searching for clues in the theft of prescription narcotics and cash from three Broward County drug stores, including one incident where a robber reportedly used a firearm.

WA Pharmacy owner Wesla Hargrove told Broward Sheriff’s Office deputies she was behind the counter of her Pompano Beach store when, at 4 p.m. on March 11, she heard breaking glass. Then she saw a man jump through the shattered opening and over the counter before he pointed a gun at her head.

The robber demanded drugs and money, and took 2,000 oxycodone pills and less than $1,000 in cash from the store at 437 E. Atlantic Blvd., according to the incident report.

The robber jumped back through the broken glass opening. He ran past two witnesses he had earlier ordered to the floor, as Hargrove fired her own gun at him, the Sheriff’s Office said.

The bullet struck the top front window, investigators said. It missed the robber described as 5-foot-8 and slim, and wearing a gray hooded sweatshirt over blue jeans, gloves, and a mask that revealed only his eyes.

A witness told investigators she saw the robber get into a small red car with a male driver who could barely see over the steering wheel.

In Fort Lauderdale on Sunday night, a burglar was captured on video breaking into the MedEx Pharamacy at 1399 SE 17th St.

Detectives believe the suspect climbed onto the roof around 9:30 p.m., peeled back an access panel and, once inside, took prescription narcotic pills and an undisclosed amount of money.

The burglar is described as 28 to 33, 5-foot-10, and 180 pounds. He wore a white, long-sleeved shirt, pantyhose over his face and dark jeans.

After the theft, he broke the glass front door and fled on foot, said Detective Travis Mandell, a spokesman for Fort Lauderdale police.

The owner of MedEx Pharmacy said he recently stopped stocking oxycodone because thieves were targeting drug stores, seeking that narcotic. Crackdowns on pill mills have been restricting supplies, he said.

Mandell said he was not aware of such a trend, and Sheriff’s Office spokeswoman Keyla Concepcion said the agency’s robbery unit has not seen a spike in pharmacy robberies.

Earlier this week, the Sheriff’s Office announced a search for a burglar nicknamed “the Houdini Bandit,” who was captured on video climbing through the front door grate of another Pompano Beach pharmacy, Drugs 4 Less.

High Street Pharmacies sell Viagra without Prescriptions

Up until now only Boots and Tesco Pharmacies have been able provide erectile dysfunction and malaria services to supply prescription medications without a doctor. Now Independent Pharmacies can do the same, offering Viagra, Cialis and Levitra, and Malarone and Doxycycline using ‘Patient Group Directions’(PGDs).

PGDs are instructions which allow Pharmacists to supply prescription medications. Training for Pharmacists takes place online for as little as £45.00 per year at Pharmacy PGD.

Pharmacies set their own prices for services and can recover their initial set-up cost by using each PGD with customers 3 to 4 times in a year. The erectile dysfunction PGD allows repeats of Viagra, Cialis and Levitra to be supplied for up to a year after an initial assessment.

Pharmacists who are trained can download the forms they need and start using the PGDs with customers straight away. Pharmacists pay nothing until after they train and successfully complete an online assessment. There are no extra costs involved, just a one-off annual fee after training and an annual online refresher.

Patient assessment forms and in-store guides are all available as downloads from the training website Pharmacy PGD. Inexpensive point-of-sale materials (posters and counter leaflets) are also available to order.

Registration on the ‘Pharmacy PGD’ website allow owners and Superintendents to see at a glance which of their Pharmacists are trained to use PGDs.

PGDs keep pharmacy customers loyal and out of the thrall of the sometimes dominant multiples. Private PGDs allow the independents to compete.

Pharmacy premises indemnity insurance routinely covers the use of private PGDs. PCTs are not involved in providing private PGD services.

The standards required for the safe delivery of services are all on the Pharmacy PGD website. The training is streamlined, efficient and interesting, and it counts towards Continuing Professional Development (CPD).

There is no lower cost private PGD service available, and at least one other private PGD service which is much more expensive.

Pharmacists can register free at Pharmacy PGD and try it out. We think Pharmacists will be pleasantly surprised.

‘Pharmacy PGD’ receives lots of praise for being the first and by far the lowest cost provider of these new PGDs. Pharmacists and their customers appreciate the service.

Irish pharmacy goes multi-channel

Ireland’s fastest growing pharmacy, health and beauty retailer, Sam McCauley Chemists, has selected K3 Retail to drive its multi-channel strategy.

The pharmacy chain is hoping K3 Retail will be able to help it grow and expand its business, even given the current state of the Irish economy.

Paul Maher, finance director, Sam McCauley Chemists, said: “We have very clear and focused objectives; growing sales with a total focus on our customers and their shopping experience whilst carefully managing stock and driving efficiency in our business – the system will help us in all of these areas and we see a fantastic payback on our investment.”

The integrated solution will bring together stores, online and head office operations and will help the pharmacies develop new sales channels and focus on customer engagement.

We want to deploy the latest marketing and CRM techniques to enable us to expand sales of our beauty products and services in our beauty salon business

Paul Maher, Sam McCauley Chemists

It covers EPoS, e-gift and customer loyalty, a new customer website along with central systems delivering merchandising, warehousing, financial management and business intelligence.

Maher added: “We want to deploy the latest marketing and CRM techniques to enable us to expand sales of our beauty products and services in our beauty salon business.”

According to the company, Sam McCauley will be able to manage replenishment at a local level more effectively, and the central control of data provided will help improve buying terms.

Maher continued: “K3’s combined retail expertise and knowledge of the pharmacy market was evident immediately to us and we selected them because we have confidence in their solution and in their people’s ability to deliver the system quickly, matching our ambitions to improve how we run our business.”

John Little, sales director, K3 Retail, said: “We are delighted that we can match Sam McCauley’s clear vision and that they have selected every single facet of our solution in store, at head office and for marketing, to ensure the ongoing expansion of this amazing Irish success story.”

Shortlink

Pharmacy News Online: Man had child-pornography developed at pharmacy

Man had child-pornography developed at pharmacy

A Fredericton man who had pictures of child pornography developed at a northside pharmacy told a judge Wednesday he’s not into sexual imagery of children.

Eugene Carvell Campbell, 64, of 298 Union St. pleaded guilty Wednesday to a Dec. 13 charge of possession of child pornography.

Crown prosecutor Karen Lee Lamrock said Campbell was caught with the illegal material because he took four rolls of film to the Shoppers Drug Mart on Main Street to be developed.

Once he had the negatives, he asked for specific images to be printed, she said. A clerk printed an index card of the images so Campbell could choose which ones.

“When she did so, she noticed that a number of the pictures had young males in their underwear,” Lee Lamrock said.

In one of the pictures, the genitals of a young male were visible, she said.

“The police arrived and seized the photographs,” she said.

All of the young males in the illegal images appeared to be between the ages of 10 and 13.

Lee Lamrock said the circumstances of the case are unusual in several respects. First of all, the pictures were photographs of images displayed on a computer screen, she said, and the pictures don’t appear to be ones that are online.

“Who (the boys) are, we don’t know,” Lee Lamrock said. “We don’t know where the computer is.”

Campbell told the court the computer in question was his but he had thrown it out because it no longer functioned.

Lee Lamrock said that while the material in question seems to be on the lower end of the child-pornography spectrum, it’s clear the pictures of the young boys were meant to be sexually enticing.

Another oddity of the case, the prosecutor said, is the fact that Campbell told police he was hired by an unknown man to take the photographs and print them.

The fact that he had these images because he was paid for them is an aggravating factor, she said.

“Honest to God, I did not realize the shot(s) in question were child porn,” Campbell told the court.

“I’m not into kids. I’m gay, I admit, but (I’m into) older guys.”

He said he only knows the man who hired him as John and doesn’t know how to contact him.

Campbell said the man brought him the images on discs and asked him to photograph them and print them.

He said he was uncomfortable with the images and refused to process some nudes for the unknown individual.

“He said he was going to ruin me,” Campbell said, noting he felt he was coerced into co-operating.

He also admitted he desperately needed the money the man was paying him to do those things.

Campbell said he only took 10-15 pictures for the man, who’d brought him several hundred.

“I needed the money real bad … I did feel uncomfortable,” he said. “I’ve done nude photography of adults, I admit.”

Since he was charged with possession of child pornography, his life has fallen apart, Campbell said.

Family members with children have cut off contact, he said, and friends have shunned him.

Campbell has lost work as a result as well, defence lawyer Edward Derrah said, noting that a couple who had hired him to photograph a wedding cancelled after they learned about the charge.

“I’m virtually ruined … I’m told I may be evicted from my apartment because of this,” Campbell said, noting he’s also received some nasty phone calls as a result of media coverage of his case.

Lee Lamrock asked for a jail sentence of 30 days, while Derrah argued that no more than the mandatory minimum of sentence of 14 days should be imposed.

Sam’s Club launches preventive healthcare program with pharmacists

Warehouse retailer Sam’s Club has initiated what may be the country’s largest retail preventive healthcare program targeting consumers and small businesses. Launched in January to coincide with the annual wave of New Year’s resolutions, The Prevention Plan is an online health-screening and primary prevention program similar to wellness plans already being marketed to employer groups. It costs $99.

Sam’s Club is also launching free monthly in-store health-screening programs that include an individual pharmacy consultation, blood-pressure checks, bone-density scans, BMI assessment, cholesterol and blood-glucose testing, hearing exams, and eye exams.

Two crises in one

“We have a health-cost crisis because we have a health crisis,” said Ronald Loeppke, MD, vice chairman of U.S. Preventive Medicine Inc., which created The Prevention Plan. “The way to deal with that is through prevention. Primary prevention can produce significant reduction in health risks over just a 12-month period.”

“Our mission is to make the world a healthier place,” Loeppke said. “Health doesn’t need to be limited to people whose employer decided to offer a wellness program. Let’s make it available to individuals and family members who are not associated with an employer benefit plan. Prevention has the clinical evidence to show that it really works. Prevention is an idea whose time has finally come.”

The evidence for prevention

The evidence is a 12-month study published in Population Health Management in November 2010. Loeppke and fellow researchers followed 2,606 participants from numerous employer groups. They tracked the incidence and severity of 15 risk factors for diabetes, cardiovascular disease, and other preventable chronic conditions.

Results showed that with 24/7 nurse hotlines, one-on-one health coaching, contests, group events, and employer incentives, the high-contact program significantly reduced the percentage of employees with high-risk blood pressure (42.8%), fasting blood glucose (31.1%), stress (24.9%), and 8 other risk factors for individual participants.

The program also significantly increased the percentage of patients who moved from high risk to intermediate risk or low risk and from intermediate to low risk based on the number and severity of risk factors. Risk factors in this category included body mass index, smoking, elevated blood pressure, elevated cholesterol, fatty diet, physical activity, excessive alcohol use, recreational drug use, seat-belt usage, days of illness in the previous year, and other measures.

How it works

The individual Prevention Plan begins with an extensive health questionnaire and a self-administered finger stick to assess cholesterol and HbA1c levels.

Each patient receives a personalized health-risk evaluation, specific recommendations and action plans to reduce health risks, health-education resources, and personal coaching sessions by telephone or web-based chat.

Participants also receive a prevention schedule that lists all recommended screenings and immunizations based on age, sex, and reported risk factors derived from U.S. Preventive Task Force guidelines.

The pharmacists’ role

The Prevention Program includes a detailed section on medication use, including prescription products, OTCs, and supplements, Loeppke said.

Pharmacists play key roles in medication management and adherence, important aspects of successful tertiary prevention. Pharmacist participation can also strengthen primary/secondary prevention.

“Pharmacists are well recognized as trusted resources and health advisors,” Loeppke told Drug Topics. “We see potential for pharmacists to be a very important stakeholder in this effort.

“We have a great sick-care system that is reactive and illness-oriented. We need to build on that to be more of a proactive, wellness-oriented system as well.”

The People’s Pharmacy: Coconut cookies can help calm chronic diarrhea

After months of daily diarrhea, my teenage son underwent biopsies and was diagnosed with Crohn’s disease. Gluten can sometimes be irritating for people with Crohn’s, so we are trying to avoid it in his diet.

That means we can’t use store-bought coconut macaroons, though we read in your column that they could help calm diarrhea.

I have modified the recipe on the package of coconut to make him macaroons.

He’s been eating them for the past couple of weeks, and the constant diarrhea has subsided. Best of all, he is starting to gain back some of the 22 pounds he lost during the past few months before he was diagnosed.

Here’s my recipe:

Mix 6 tablespoons sweet rice flour, 1/4 teaspoon salt, 1 teaspoon almond extract, 4 egg whites, one 14-ounce package of shredded coconut and 1/3 cup chocolate chips. Drop onto a cookie sheet and bake at 325 degrees until the tops turn light brown, about 15 or 20 minutes.

Thanks for sharing your remedy. It sounds delicious. Many people with the inflammatory digestive-tract disease known as Crohn’s suffer from chronic diarrhea.

In fact, we first learned about coconut macaroon cookies for this problem from Donald Agar, a Crohn’s patient.

He discovered the benefits for himself and notified us so we could alert others.

He found that two macaroon cookies daily controlled his diarrhea.

I read that turmeric could help relieve muscle pain, so I began taking three capsules each day for my fibromyalgia. The pain has eased somewhat, but the greatest benefit was that the neuropathy in my feet has almost entirely disappeared.

After two weeks, I urged my sister, 10 years younger than me and with a much more severe neuropathy problem, to try it. She began taking turmeric and is almost completely pain-free.

Neuropathy can manifest as numbness, tingling or pain in hands or feet. This kind of nerve disorder is notoriously hard to treat.

Turmeric has long been used in the traditional medical systems of Asia. Malaysian scientists confirmed last year that an extract of this bright-yellow spice could quell nerve-related pain in rodents (Molecules, April 22, 2010). The anti-inflammatory activity of turmeric also may provide benefit.

Thanks for writing about ginger tea for colds. I’ve been fighting a bad cold for several days. When I read about this, I used a potato peeler to cut thin slices of ginger. I put them in a cup of water and stuck it in the microwave. After two minutes, I added a little sugar. My congestion felt better even before I finished the drink.

We are big fans of ginger tea for congestion. Your approach sounds simple and tasty. Ginger does not have the side effects found with many over-the-counter cold-symptom relievers.

Shortlink

Pharmacy News: Canadian Pharmacy & Online Drugs Leader Cautions Media’s Meds Hype Unnecessarily Costing Americans

Canadian Pharmacy & Online Drugs Leader Cautions Media’s Meds Hype Unnecessarily Costing Americans

A leading Canadian online pharmacy, NorthWestPharmacy.com is concerned about media hype driving sales of drugs such as Tamiflu at the expense of patients. While Tamiflu is indicated for both treatment and prevention of the flu, the indications are fairly specific in terms of when the drug should be taken to be effective and the type of flu virus it is actually effective against. The Canadian online drugs retailer warns consumers that many media articles fail to provide the particulars of how the drug works, side effects or whether the drug is in fact worth shelling out cash for.

“I think some news articles in the USA are more like advertisements for drugs than they are useful or informative to patients,” says Aman Bhangu, Canadian Pharmacy Manager for NorthWestPharmacy.com. He holds up a print out of a recent “news” article regarding Tamiflu, published by a major U.S. news outlet which describes a so-called shortage of Tamiflu suspension that reads like a high pressure pitch to rush out and buy the drug.

Why would one of the largest Canadian online pharmacies caution consumers about buying certain online drugs? Having earned many years of experience running national chain pharmacies in the USA and Canada prior to serving NorthWestPharmacy.com’s Canadian drugs patients, Pharmacist Bhangu says it is all about the best interests of his American patients. “This article makes it sound like Tamiflu is a cure all in short supply but I only recommend patients spend their money on a drug therapy that they will derive a significant benefit from,” he says. He counsels patients to take media hype regarding drugs and pandemics with a grain of salt by considering whether any private interests like big pharmaceutical makers stand to gain from this hype. Most importantly, patients should speak with their pharmacist or doctor and do independent research about any proposed drug therapy.

How to save time and money when buying pet meds

You can’t put a price on the joy your pet brings you, but there’s also no disputing the fact that owning a pet is expensive. Visits to the veterinarian, food and medications all add up and can put a strain on your cash flow. The good news is there are ways for pet owners to save money, particularly when buying common pet meds.

Whether we are purchasing medications for ourselves or our pets, our first instinct is not to worry about cost, only about getting the proper treatment. However, it’s possible to save money on frequently recommended over-the-counter pet meds like Frontline Plus for dogs and Dasuquin, as well as prescription medications, without negatively affecting your pet’s health.

Here are a few ways you can save when buying medication for your pets:

* Buying in bulk. If you know you’ll be using a lot of a certain medication, you will likely be able to save money when buying larger quantities.

* Buy the generic version. When receiving a prescription from your doctor, ask if there are generic versions of the drug that are just as effective. As with anything else, you may be paying more for the name than you are for the drug itself if you go with a brand-name medication.

* Shop online. Today, more and more online pharmacies, such as VetDepot, offer low prices on both prescription and over-the-counter pet meds.

While there are many reputable online pharmacies, there are also sites that are out to scam customers with counterfeit or out-of-date medications. Therefore, it’s important to take some precautions, whether you are buying drugs from a bricks-and-mortar pharmacy or online. The U.S. Food and Drug Administration recommends following the acronym A.W.A.R.E. when buying pet meds online:

A – Ask your veterinarian about the site you plan on using to buy the medications to find out if they have had any experience with or direct knowledge of the site.

W – Watch for red flags. Avoid sites that don’t require prescriptions for prescription drugs and do not have a licensed pharmacist available to answer any questions you may have. Stick to sites that are based in the United States, as only those sites can be regulated by the U.S. government.

A – Always check for site accreditation. The National Association of Boards of Pharmacy has a program that accredits online pharmacies that voluntarily undergo reviews each year. Sites that have this accreditation should display that they are Vet-VIPPS accredited.

R- Report problems and suspicious online pharmacies. In addition to contacting your vet if problems occur after your pet has taken medication you purchased online, you can also call 1-888-FDA-VETS to report any suspicious activity you encountered when working with a pharmacy.

E – Educate yourself about online pharmacies. The Center for Veterinary Medicine offers a number of resources on its website that can provide you with information about online pet med providers.

By being an informed and thrifty shopper, you can help your pet stay healthy while saving a few dollars in the process.

Enhances Availability of Information on Prescription Savings Programs; Adds Resources About Healthcare Access Options

In a changing healthcare environment, many Americans need help navigating healthcare options and understanding how they and their families can best access resources to help them take better care of their health. Together Rx Access®, a prescription savings program sponsored by many of the nation’s leading pharmaceutical companies, has significantly redesigned its website — TogetherRxAccess.com — to better connect people to valuable health information and resources.

Visitors to TogetherRxAccess.com can continue to determine eligibility and immediately enroll in the Together Rx Access prescription savings program. In addition, they can now access resources that can help them learn how healthcare reform may impact them and their families, uncover ways to better manage chronic conditions, and connect with others who are also striving to maintain healthy habits. The website also allows healthcare professionals and other community leaders to order Together Rx Access materials and contribute content to the site by authoring articles and guest columns.

“In our conversations with uninsured individuals, healthcare professionals, patient advocates, and our cardholders, we are frequently asked for more information and resources about access to healthcare — in addition to prescription savings,” said Roba Whiteley, executive director of Together Rx Access. “By redesigning our website to include valuable health resources, such as links to healthcare reform information, podcasts of health tips, and guest columns by health experts, we are responding to this need and helping people take better care of their health.”

TogetherRxAccess.com continues to offer key information about the prescription savings program that cardholders have come to rely on including: eligibility requirements, online enrollment, pharmacy locator, and a list of brand-name prescription medicines and products included in the Program.

Programs like Together Rx Access can help eligible uninsured people access the medicines they need while they wait for healthcare reform to be implemented. This is critical as results from a recent consumer poll showed that nearly half (44 percent) of the uninsured may delay seeking health insurance coverage while waiting for healthcare reform.*

About Together Rx Access
With Together Rx Access, uninsured Americans gain access to immediate savings on prescription products right at their neighborhood pharmacies AND resources that help people take care of what’s most important…their health.

The Together Rx Access Card was created by many of the nation’s leading pharmaceutical companies to help hardworking Americans and their families gain access to immediate and meaningful savings on prescription products right at their neighborhood pharmacies. Most cardholders save 25 to 40 percent† on brand-name prescription products. Medicines in the Program include those used to treat high cholesterol, diabetes, depression, asthma, and many other common conditions. More than 300 brand-name prescription products are included in the Program.‡ Savings are also available on a range of generic products.

The companies participating in the Together Rx Access Program include Abbott Laboratories; Bristol-Myers Squibb Company; GlaxoSmithKline; Janssen, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; King Pharmaceuticals, Inc.; LifeScan, Inc.; McNeil Pediatrics, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Ortho Dermatologics, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Ortho-McNeil Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Ortho-McNeil Neurologics, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Ortho Women’s Health & Urology, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Pfizer Inc; PriCara, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Stiefel, a GlaxoSmithKline company; Takeda Pharmaceuticals North America, Inc.; Tibotec Therapeutics, a Division of Centocor Ortho Biotech Products, L.P.; ViiV Healthcare; and Vistakon Pharmaceuticals, LLC.

Shortlink

Pharmacy News: Linkam Partner with BTL to Produce Solutions for the Pharmaceutical Industry

Linkam Partner with BTL to Produce Solutions for the Pharmaceutical Industry

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments, and freeze drying technology, Biopharma Technology Limited, celebrate ten years of partnership in supplying solutions to the pharmaceutical industry.

Biopharma Technology Limited (BTL) was founded in 1997 to develop freeze drying solutions to multiple materials in the world of pharmaceuticals. Freeze drying, also known as ‘lyophilisation,’ is a method of processing a liquid product into a dry solid product. The early days of the company saw homemade instrumentation based on ideas originating at Porton Down. However, in 2001, Director of Research at BTL, Dr Kevin Ward, came across Linkam and their range of temperature controlled stages. Freeze drying had often been a conducted in a hit and miss process without clear knowledge of the critical temperatures needed to produce the best product. The ability to provide accurate thermal characterisation right down to -196°C took the guesswork out of the process quickly and simply.

The two companies went on to develop a number of instruments, the latest being the Lyostat 3 freeze drying microscope. Dr Ward, understanding that a scientific approach was critical to the development of the process, has gone to perform contract work looking at more than 700 samples from companies worldwide. Being able to optimize the freeze drying temperature greatly aids the formulation in a vast family of biotech, pharmaceutical, diagnostic and agrochemical applications. The combination of BTL’s applications knowledge and Linkam’s instrumentation expertise brings a real added-value product to the freeze drying market place.

A typical experiment will look at the temperature at which a product undergoes collapse as this is the single most important characteristic for almost all freeze drying formulations. The Lyostat3 system uses polarized light microscopy to capture images of the sample’s structural changes as temperature increases, information that is vital for successful freeze drying. This data is invaluable when developing a freeze drying cycle from scratch or in helping to identify the small adaptations in a freeze drying cycle that can transform the process operating costs. The advantages of a tailored production process are obvious; research has shown that a 1°C increase in product temperature can result in as much as a 13% increase in primary drying rate, demonstrating that thermal accuracy can transform process operating efficiency and costs.

The collaboration has also brought benefits to BTL through being able to provide quality pictures to illustrate the process at varying precisely controlled temperatures and pressures. For Linkam, it has been the benefit of being at the leading edge of an exciting and growing market. Freeze drying is growing. Whereas it used to be solely the domain of big pharma companies, it is now the smaller, specialty businesses in the fields such as biotherapeutics and biopharmaceutics that are using the BTL technology to study bigger, more complex molecules.

Fette opens pharma testing centre in Goa

Chennai-based Fette Compacting Machinery India Pvt Ltd (FCI), the Indian subsidiary of the Germany-based machine tool manufacturer Fette Compacting, has launched competence centre in Goa to provide tablet compression testing and related services for pharmaceutical industry in India.

The company, which imports and serves tablet pressing machines to the Indian pharmaceutical companies, would provide laboratory facilities for compression trials and sample production, basic trials to analyse material properties of tablet mixture and support in proof of concept studies for Indian clients through the facility, said Venkatasubramanian, managing director, FCI.

The competence centre is set up with an investment of around Rs 5 crore. The facility is also equipped as a training centre to provide hands on training to the employees of the pharmaceutical clients to handle the high end machines.

The centre is basically to support our clients in India, both the domestic and multi national pharma companies which has manufacturing facilities in India, to test and analyse the flowability and compressibility of their tablets thus improving the quality of the end products, said Venkat.

Besides, the company is also evaluating options to set up an engineering and development centre to develop machine tools for Indian pharmaceutical industry.

At present, the machines are imported from China and Germany for Indian customers. Plans to set up a development centre in India is on the drawing board, but is in a nascent stage to reveal more, he said.

FCI, launched in India in 2006 as a division of Fette Germany, became a subsidiary company in 2010. It has so far installed around 80 machines in the country and targets to complete sales of around 35 to 40 machines this year.

In the last fiscal year, the company has closed revenue of around Euro 10 million (approximately Rs 64 crore). It is expecting to clock in a revenue of around Euro 14 million (approximately Rs 88 crore), he added.

Shortlink

Pharmacy Industry News: Van Vliet suddenly leaves KV’s interim CEO job

Pregnancy drug’s huge price hike stuns patients, doctors, insurers

The cost of a popular drug to help prevent preterm labor is increasing by 100 times, a revelation that has stunned pregnant women, their doctors and pharmacists this week.

“I’m ready to have a heart attack,” Janice Watkins, a Pittsburgh resident who is pregnant and has been taking the generic drug known as 17P, said Thursday after she learned of the price increase from her doctor’s office. “I’m nervous now because I have to go home and call my insurance company to see if they’ll cover me.”

Typical doses of 17P that now cost $10 to $20 per dose will have a list price of $1,500 under the brand name Makena. That’s because KV Pharmaceutical of suburban St. Louis last month won government approval to exclusively market and sell Makena, a synthetic version of the hormone progesterone.

Doctors and health care advocates worry that some women who need the drug will not be able to afford it or their insurance companies will no longer cover it.

“I don’t think there’s any question that fewer women will use it now,” said Ronald Thomas, director of maternal-fetal medicine for West Penn Allegheny Health System, where 60 to 80 women a year use the drug. “Insurance companies may be happy to approve it if it was $250 to $300 (per person) but they may take a second look at it if it’s a $25,000 to $30,000 charge.”

The drug’s estimated total cost during a pregnancy could reach $30,000. High-risk women — those who’ve had difficulty bringing a prior birth to full term — can take the drug for up to 20 weeks during pregnancy.

When Thomas first heard about the price increase Thursday, he said, “I thought it must have been a misinterpretation of the cost. You can’t describe this as anything other than greed.”

KV Pharmaceutical said in a statement that it “has made significant investments to advance Makena through the FDA-approval process and make it available to patients who need it and have a significant obligation in the form of a large, ongoing clinical study. The company has also made a significant investment in developing a network of specialty pharmacies, specialty distributors and a comprehensive customer support center.”

The list price is $1,500; the company said the actual cost to patients should be substantially lower than that, depending on their coverage. It also said it would assist low- and no-income women in paying for the drug at little or no cost.

What bothers doctors, pharmacists and patients about the cost is that Makena is merely a rebranded version of a drug that had been in use for 50 years but had gone out of use 11 years ago, earning the “orphan” drug status. It had been used for disorders of the adrenal glands or the ovaries.

It gained new attention after a 2003 National Institutes of Health-funded study found that only 36 percent of women at risk of preterm labor who were given 17P had premature birth, compared with 55 percent of women who were not given the drug.

Since then, with no FDA-approved version of the drug commercially available, special pharmacies that custom- compound treatments have been churning out individual doses — typically five or 10 doses per vial — with positive results.

Because of KV’s exclusivity right, compounding pharmacies are no longer allowed to produce the drug beginning next week.

Van Vliet suddenly leaves KV’s interim CEO job

Struggling KV Pharmaceutical Co. said David Van Vliet has been replaced as interim CEO by the head of the company’s branded drug unit.

The company provided no details about Van Vliet’s departure, only that it will search for a permanent CEO. Meanwhile, Gregory J. Divis, president of KV’s Ther-Rx subsidiary, will take over on an interim basis.

KV spokeswoman Catherine Biffignani declined to comment on the transition. Van Vliet also declined to comment when reached at home Friday afternoon.

The shake-up at KV continues a tumultuous run for the company whose products were pulled from pharmacy shelves in 2008. Since then, manufacturing operations have been idled until KV complies with federal rules on drug-making practices. A subsidiary pleaded guilty to federal charges of failing to inform regulators that it was making oversized tablets. And the company has laid off more than three-quarters of its employees.

The biggest question surrounding KV these days is its ability to remain afloat while waiting for approval from the Food and Drug Administration to restart production.

“It has been a difficult period for KV,” Divis said in a statement. “I and the board of directors are committed to doing all that we can to restore KV’s revenue stream and shareholder value.”

KV said the board is focused on working with the FDA and continuing to explore financial alternatives to strengthen cash holdings.

Earlier this month, KV sold its Particle Dynamics unit for $24.6 million.

Van Vliet joined KV in 2006. He was named interim CEO in December 2008 when Marc Hermelin, the firm’s longtime chief executive and founder’s son, was ousted following a probe by the board’s audit committee.

Hermelin retained his board seat and, with help from his family and allies, led a successful push last year to change KV’s bylaws to give controlling shareholders more power.

At the company’s annual meeting Thursday, shareholders re-elected Hermelin to the board along with his brother David Hermelin, Chairman Terry Hatfield and director John Sampson.

KV said Friday that Marc Hermelin will serve the board on a “transitional” basis and will not return to the company as an officer or employee.

Three new directors were also approved: Mark A. Dow, Gregory Bentley and Joseph D. Lehrer. All will serve one-year terms.

Divis, the new interim CEO, joined KV three years ago after spending almost 18 years in the pharmaceutical industry with companies including Shering-Plough Corp. and Sanofi-Aventis.

KV hopes to obtain FDA approval to restart drug production later this year. The company signed an agreement to market and sell Gestiva, a drug intended to prevent premature birth. Under the agreement, Baxter Pharmaceutical will manufacture the drug, and KV will bring it to market.

But plenty of challenges remain, including remaining financially viable until it gets FDA approval. KV also faces a number of lawsuits from patients and their families and a $100 million suit from CVS Pharmacies, which claims that KV broke a supply contract.

Drug price infuriates those who help moms

Local health advocates have gone from hopeful to angry after a drug designed to prevent premature births was approved by the FDA only to go up in price about 100 times its original cost.

At first, Ohio doctors were thrilled that the U.S. Food and Drug Administration approved injections of the synthetic hormone progesterone, meaning the drug would be easier for women to obtain.

But after the FDA gave the go-ahead last month, the manufacturer of Makena announced it would now cost $1,500 per dose, roughly 100 times the former price.

” Outrage is the best word to describe it,” said Jay Iams, a doctor of maternal fetal medicine at Ohio State University Medical Center. “We had been so delighted and cheering for them, but when we heard the price, it felt like Satan had just purchased your favorite sports team.”

Iams and other health professionals with Ohio Better Birth Outcomes, a team of hospitals and clinics in central Ohio that works to prevent premature births and treat the effects of early deliveries, said this setback won’t stop their work.

At least 336 women were enrolled in the organization’s progesterone-injection program in 2009, and 480 were last year, said Pam Carr, executive director of Partners for Kids and one of the developers of Ohio Better Birth Outcomes.

Carr said that use of the hormone already has shown signs of helping at-risk women stay pregnant longer.

Franklin County is one of the primary funding sources for the program. Commissioners had planned to approve the next $500,000 payment of their $7million pledge next week.

Commissioner Paula Brooks said pressure should be put on the pharmaceutical company to reconsider the price.

“I’m really mad about this,” she said yesterday. “What the heck is going on here? The company is killing children if this drug is withheld from mothers who need it because of price gouging.”

The March of Dimes has said that, if all at-risk women who are eligible used the drug, it could prevent almost 10,000 premature births a year nationwide. But if the cost is prohibitive, that might prevent many women from getting it, especially low-income women, who have a higher rate of premature births anyway.

The drug has been around for years from specialty pharmacies, at a cost of $10 to $20 per injection, with weekly injections required. That typically amounted to about $300 over the approximate 20 injections a woman needed from when she was about four months pregnant until she delivered.

The FDA approval means Makena will be more readily available at all pharmacies, but also means that K-V Pharmaceutical Co. of St. Louis has exclusive rights to it for seven years. At $1,500 per dose, that could cost a woman about $30,000 throughout the pregnancy.

Still, the health advocates said they remain hopeful of change. K-V Pharmaceutical said this week that it will establish a program to provide the drug to low-income women until Medicaid kicks in to pay for it.

If the injection price does turn out to be prohibitive, pregnant women can use a vaginal suppository of the same hormone that would cost about what the injections used to cost over the term of the pregnancy.

But Carr said that the suppository has to be administered daily, which increases the likelihood of a woman forgetting a dose.

Shortlink

Pharmacy News: Cabbarrus College offers new online pharmacy technology degree program

Cabbarrus College offers new online pharmacy technology degree program

Cabbarrus College of Health Sciences, which is located in North Carolina, recently unveiled a new associates degree in pharmacy technology, the Charlotte Observer reports.

Officials told the news provider that the program is a result from discussions with hospital and community pharmacy workers who identified that more professionals were needed in the industry.

They added that the curriculum will involve 69 credits, which can be obtained through online, hybrid and traditional classroom courses. Students can also earn certificates in health services leadership for those who wish to pursue lead technician or management roles.

According to the Bureau of Labor Statistics, the average hourly wage for pharmacy technicians equates to $13.32.

Students will work under licensed pharmacists and perform jobs such as packaging medications, preparing IV admixtures, helping dispense and deliver medications as well as maintaining patient profile records. The school also offers associates degrees in medical assisting, nursing, occupational therapy assistance, surgical technology and science.

According to U.S. News and World Report, enrollment in online programs has increased by 832 percent over the past the past nine years.

Internet drug scams can make you sick

BOSTON (MarketWatch) — Thinking of taking advantage of that super deal you just go emailed by an online pharmacy? Buyer beware: What looks like a fabulous deal on Lipitor could end up being a box of counterfeit drugs that will not only fail to lower your cholesterol but could be hazardous to your health.

Industry experts say a dismal economy is pushing more consumers to seek out prescription drugs on the Internet. But claims of deep discounts are often red flags that the site is bogus, and what you end up receiving in the mail could very well be counterfeit, stolen or even contaminated.

“Business is booming, unfortunately, especially in a down economy, where people think they can cut corners to save a buck,” said Special Agent in Charge Bruce Foucart of the U.S. Immigration and Customs Enforcement, or ICE.

“The problem is the drugs you get might not be potent enough or could even make you sick,” he said.

Or worse. Fake drugs are behind an estimated 700,000 deaths from malaria and tuberculosis, according to a 2009 report from International Policy Network, a nonpartisan think tank.

The World Health Organization estimates that fake drugs comprise 10% of the global medicine market, and 25% of the market in developing countries, according to a 2006 report.

Experts say that consumers need to keep in mind that while medications bought through Internet-based pharmacies can be a bit cheaper, the prices don’t vary that radically from those offered at brick-and-mortar drug stores. And consumers should be extremely wary of sites that claim they can dispense drugs without a prescription, which is in violation of U.S. law.

The biggest problem with counterfeit medications is, quite simply, you don’t know exactly what’s in them. The level of the active ingredient needed could be too low to be of any therapeutic value or dangerously high. Or it might not be present at all.

The product could also be contaminated with stray material, as many counterfeit drugs are produced by foreign, third-party manufacturing plants that fall outside of the realm of regulators such as the U.S. Food and Drug Administration. Another common stunt, according to ICE, is for traffickers to substitute cheaper over-the-counter drugs for more expensive prescriptions medications.

Last June, for example, FDA investigators uncovered a bogus Internet pharmacy advertising it could sell the popular flu medication Tamiflu without a prescription. An inspection of the shipped product showed that it wasn’t Tamiflu, a Roche (CH:ROG 132.20, +0.10, +0.08%) product, but a cheaper, penicillin-like product that
could’ve triggered a potentially deadly reaction in anyone allergic to penicillin.

Similarly, another FDA bust revealed that a website advertising the diet drug Alli at discount prices was actually shipping the drug sibutramine, also known as Meridia, an Abbott Laboratories product (ABT 48.70, +0.20, +0.41%) which was recently yanked from the market over safety concerns.

And just because the shipped product looks like the real thing doesn’t mean it is. Indeed, many experts complain that counterfeit packaging has become so slick, even they have a hard time distinguishing between a fake and the genuine article.

“You have to be cautious about where you’re buying from…because the counterfeiters are so good now in making copies of the real thing,” said Ilisa Bernstein, a deputy director for compliance at the U.S. Food and Drug Administration. “The technology has become more sophisticated.”

Village offers prescription drug discount card to residents

Wellington residents who don’t have health insurance or have prescriptions that are not covered by their insurance are now able to receive a discount on prescriptions with the National League of Cities prescription discount card available online and throughout the community.

“Residents will be able to get medication for a discounted price,” said human resource generalist Rose Taliau. “Discounts average about 20 percent and cost nothing for residents.”

The program is provided through CVS Caremark in collaboration with the National League of Cities.

“Wellington residents are able to participate in this program because of Wellington’s involvement in the League of Cities,” Taliau said. “If a city would like to participate in the program then they [National League of Cities] provide all the materials and information.”

The card is offered to all residents, said Christine Cramer, director of public relations for CVS Caremark. There are no age or income restrictions. She added that saving will vary by drug and by pharmacy, with more than 59,000 pharmacies nationwide pharmacies participating in the program.

“There is no cost to the resident or the city,” she said. “There are no enrollment fees or membership fees.”

Taliau said that the cards are available throughout Wellington at city hall, the community center, the Safe Neighborhoods Office and at the Village Park gymnasium as well as online at http://www.caremark.com/nlc.

“The website also shows residents which pharmacies will take the card,” Taliau said.

The program has additional features including a toll-free number, 888-620-1749, that along with the website provide residents with program tools and information, Cramer said. The website also provides prescription prices and health resources.

CVS Caremark has been administrating prescription discount programs since 1992, Cramer said. CVS Caremark derives revenue from the program in the form of a small fee that the pharmacy pays on each transaction, according to CVS Caremark documents.

Shortlink

Pharmacy News: Pharmacy Technician – Be an Integral Part of the Healthcare Industry

Pharmacy Technician – Be an Integral Part of the Healthcare Industry

Southwest Schools is offering the Pharmacy Technical Program in order to meet the growing demand. In this area of the health care industry. The PT program is offered at the San Antonio and Corpus Christi campuses.

The PT program at Southwest Schools is approved and regulated by the Texas Workforce Commission, Career Schools and Colleges, in Austin, Texas. Southwest Schools is nationally accredited by the Commission of the Council on Occupational Education (COE).

The PT program is designed to meet the current and estimated employment needs of the pharmaceutical industry. Students are provided the technical knowledge for employment in both retail and institutional settings within the rapidly growing Pharmacy Technician field. The PT program encourages students to develop strong customer service and interpersonal skills. The student will learn about fundamentals of pharmacology, common terminology and abbreviations, adverse effects of pharmaceuticals, how to fill and dispense prescriptions, and billing and coding skills. The PT program offers the opportunity to students to gain all of the knowledge and skills necessary to enter the Pharmacy Technician profession in an entry level position.

Graduates of Southwest Schools Pharmacy Technician Program may seek employment in venues such as retail pharmacy, healthcare clinics, home health agencies, long term health care facilities, and pharmaceutical companies. According to United States Department of Labor Bureau of Labor Statistics, the increasing demand for well-trained Pharmacy Technicians is expected to grow by 31% by 2018.

With ten school in seven cities throughout Central and South Texas, Southwest Schools offers a wide range of professional programs in allied health care, business, accounting, and cosmetology fields. Equipped with modern facilities and equipment and a well trained and caring staff, Southwest Schools welcomes the opportunity to train you in your future career.

When it comes to Career Training, Southwest Schools is the place to be.

Local lawmaker wants tax loophole closed to pay for drug, health programs

24th District Representative Kevin Van De Wege is pushing to end a tax loophole to fund a statewide drug take-back program.

Van De Wege has introduced House Bill 2006, which gets rid of a pharmaceutical industry tax preference.

From the additional money the state would take in, about $1.2 million would go into a dedicated product stewardship account that would fund the take-back program.

Van De Wege says the rest would help fund the state’s Basic Health Program for the working poor.

Earlier in the legislative session, Van De Wege sponsored a similar measure, with the take-back program funded and managed by the pharmaceutical industry and overseen by the state Pharmacy Board. That bill, which the pharmaceutical industry strongly opposed, didn’t make it out of committee.

The drug take-back program would allow citizens to return unused prescription medication to local pharmacies. Experts say those unused drugs are a driving force behind an increase in prescription drug abuse.

Lawmakers are working to close an approximately $4.5 billion shortfall in the next biennial budget. Van De Wege says his proposal may be able to save the state’s Basic Health Program which is in line to be eliminated due to the state’s massive budget shortfall.

Drugs in short supply

Hospitals across the country are running low on key drugs used in surgeries and to treat some diseases, including cancer.

“The shortage situation is incredibly bad,” said Nancy Ryu, a pharmacy purchasing supervisor at Loma Linda University Medical Center.

“We are trying to obtain as much medication as we can. We are restricting usage and keeping a close eye on the supplies we have.”

Similar scenarios, blamed on tougher safety rules put in place by the U.S. Food and Drug Administration, are playing out in other Inland Empire hospitals.

“We have not run out, but we do have shortages of some drugs,” said Kathy Roche, a spokeswoman for Pomona Valley Hospital Medical Center. “Obtaining the medication has created more work for hospital’s pharmacy and purchasing staff.”

Fontana-based Kaiser Permanente Medical Center has also been impacted.

“We are prioritizing the needs of our patients and managing our resources,” said hospital’s spokeswoman Jennifer Resch-Silvestri.

“We are working closely with our physicians to weigh alternatives when appropriate.”

There are about 150 drugs – triple the number from just five years ago – that are in short supply, according to the American Society of Health-System Pharmacists, a trade group that works with hospital pharmacists on ways to deal with the shortage.

About 60 of those are considered by federal health officials as “medically necessary,” and they include prescription medicines used to treat or prevent a serious disease or medical condition.

At Loma Linda University Medical Center, drugs in demand, such as Methotrexate and Etoposide, are used to treat tumors.

“Without the treatment, the cancer cells can progress,” Ryu said. “Other area hospitals are calling us to see if they can borrow medication or transfer patients over to us.”

Anesthesia-related drugs such as propofol and Neostigmine also are hard to find. The doctors at LLUMC’s dental clinic previously administered propofol to mentally-challenged patients, as they often have a hard time remaining still during treatment.

“We haven’t been able to give it to them, because we had to save it for our trauma patients,” Ryu said.

At Pomona Valley, drugs on the shortage list include amino acids, which are used in IV solutions. Calcium gluconate, used to replace calcium levels in babies born prematurely, also is running low.

Drugmakers say they are obeying FDA’s rules, which has intensified scrutiny to avoid allowing unsafe medicines on the market.

“The 2010 was the worst year ever because of the FDA scrutiny,” said Tom Dotts, a director of pharmacy at the Pomona hospital.

The quality issues can range from finding toxins and “particulate matter” in medicines to workers inaccurately filling out the required paperwork to verify that the drugs – as well as the devices used to intravenously deliver the products to patients – are safe and effective.

Even after a company restarts production of a drug, it takes time for a plant to catch up to the back orders. And injectable drugs in particular, unlike pills and tablets, tend to require long lead times to produce.

“On a weekly basis, I see 15 to 20 drug recalls,” Ryu said. “They are not advertised at all. But when there is a peanut butter or Toyota recall, it’s in the news. My staff and I spend an enormous amount of time relaying the information to physicians.”

The drug shortage is exacerbated by consolidation in the pharmaceutical industry, which leaves fewer companies making drugs.

Teva Pharmaceuticals Ltd. makes generic forms of certain cancer medications. So when quality issues temporarily closed its plant in Irvine in April, medical professionals were faced with limited supplies of an array of cancer drugs.

“If a company with a recall has a large share of the market, the smaller companies cannot meet the demands,” Ryu said.

In addition, some drug companies have exited the business of making older, generic injectable drugs, which typically aren’t as profitable as newer brand-name medicines. That puts additional production pressure on the remaining makers of these generic treatments.

Teva decided to exit the propofol business last year following a quality issue with the drug in 2009.

In a statement, the company said it believed its “existing, approved technology is not suitable to ensure that we can consistently produce the product to Teva’s high quality standard.”

Teva’s decision came around the time another propofol maker, Hospira, had to stop shipping the drug due to quality issues in its production process. Last summer, the FDA allowed Hospira to restart production. But the company said its new manufacturing process needed a certain amount of time to ramp up production and fill back orders.

The drug shortages have gained the attention of members of Congress. In February, Sens. Amy Klobuchar, D-Minn., and Bob Casey, D-Pa., introduced legislation that would require drugmakers to give the FDA an early notification “when a factor arises that may result in a shortage,” according to a joint statement.

“Several major hospitals in our state have experienced shortages that are jeopardizing patient care, and this bill will provide the knowledge required to help address and prevent future shortages,” Casey said. “Knowledge is one of the most important tools for combating problems associated with drug shortages, which are a growing threat to public health in Pennsylvania and across the U.S.”

Hospitals are finding ways to deal with the lack of availability. In some cases, they are paying higher prices to get their patients necessary care because they are working with a supplier that normally doesn’t supply them with large volumes of a product.

“The cost is up because (we are buying) custom packages, and going outside our (regular vendor) contracts,” Roche said.

Other hospitals are dealing with the supply problem by turning to alternate medicines. While these drugs can be just as effective, the lack of familiarity among medical professionals can lead to improperly calculated dosages.

“In some cases, you just can’t switch,” Ryu said. “With our pediatric patients, we follow a specific protocol. We cannot risk the lives of children by switching to medications we have no experience with.”

About 35 percent of the health care professionals responding to a survey on drug shortages said they “experienced an error that could have led to patient harm during the past year,” according to an Institute for Safe Medication Practices study released in September.

There were more than 1,000 “errors and adverse patient outcomes” reported by those in the survey. Those errors and adverse outcomes were tied to more than 50 drugs on the shortage list that became abruptly unavailable, the institute said at the time the study was released.

The drug industry believes the issue will resolve itself relatively soon, and companies say the government’s tougher rules should make consumers and medical professionals feel more confident about their products.

Teva said its Irvine facility will begin producing cancer medications, including many in short supply, this month.

And Hospira has ratcheted up spending on its manufacturing facilities and quality systems, and the company hopes to be caught up with production by the second quarter. Its chief executive, Christopher Begley, said the company’s efforts to meet the FDA’s “higher benchmark” will help the company long term.

“We see light at the end of the tunnel,” Begley said.

Shortlink

Pharmacy News: Former mayor sentenced for online pharmaceutical drug sales

Former mayor sentenced for online pharmaceutical drug sales

A well-known Miami-Dade lawyer who pleaded guilty to selling tens of millions in pharmaceutical drugs without prescriptions on an Internet site serving buyers across the country was sentenced to 40 months by a federal judge in California on Thursday. Robert Smoley, a former mayor of North Bay Village who has represented numerous high-profile clients during his career, admitted he and others distributed in excess of $48 million worth of drugs through his company, United Mail Pharmacy Services. Federal agents say the 59-year-old attorney set up an elaborate distribution network from a warehouse in Florida, where he and others shipped drugs after taking orders over the Internet and call centers in Costa Rica and the Dominican Republic. Smoley admitted to selling more than seven million pills through more 17 online pharmacy sites – with most of the orders between 2001 and 2008. ‘CHOSE PROFITS’ “The Smoley drug trafficking organization fed the habits of drug seekers while its members chose profits over the health and well-being of those customers,” said DEA special agent Anthony Williams after Smoley’s guilty plea. The onetime mayor took orders from customers who filled out online orders for medications, but no effort was made to ensure the information they provided was accurate, the plea agreement says. The orders were then reviewed by doctors who were paid between $2 and $5 per order, with some doctors approving up to 500 orders per day. Smoley admitted to encouraging doctors to review as many orders as possible each day, knowing they did not conduct physical exams – or review medical paperwork – for his customers. For years, he managed to conceal the millions his organization reaped by shifting the money through various accounts set up at U.S. banks, court records state. CAUGHT IN 2008 Though he had been under investigation for several years by federal agents in California, he was finally caught in early 2008 when he ordered more than half a million drugs from an undercover DEA agent. He pleaded guilty before federal Judge Jeffrey White in San Francisco in November to conspiracy to distribute schedule III and IV controlled substances and conspiracy to launder money. A practicing attorney since 1978, Smoley served as mayor of North Bay Village from 1980 to 1982, but left office after a controversial term in which citizens waged a recall effort against him and two commissioners. His most high profile case came in 1991 when he represented Jeff and Kathy Willets, the Fort Lauderdale couple who made international news when they set up a $2,000 a week sex business out of their home, servicing the city’s vice mayor and others. HIGH-PROFILE CLIENTS Over the course of his 33-year career, he also represented several high-power officials, including Dade Circuit Court Judge Alfonso Sepe during a bitter judicial race in 1982. Miami lawyer Richard Sharpstein, who represented Smoley during his drug case, said his client opened his business “fully believing that the Internet pharmacy was legal. Unfortunately for him, over the past five years the government has reversed its position and he was caught in the web.”

Move quickly to rein in errant pharmacists

Resistance to drugs is a major challenge in medical circles and poses a real threat to citizens’ health.

As a survey published elsewhere in this edition indicates, part of the problem are pharmacies, which routinely dispense drugs without medical prescriptions.

Up to 73 per cent of pharmacies dole out drugs on the basis of what buyers ask them, irrespective of the fact that most of them just guess what they need.

Matters are worse when these are teenagers; they are offered a chance to do experiments, which can be risky.

The practice is that people go to the pharmacies to buy drugs they believe can treat their ailments before seeking a doctor’s opinions. This is quite dangerous.

Ideally, medicine should only be given after a certified medical practitioner has done a diagnosis and identified a specific problem and suggested specific medication.

In the absence of that, what the pharmacies and the buyers do is to engage in speculative medication. The buyers end up taking drugs that cannot help them at all. Instead, their ailments continue as they develop resistance to drugs, multiplying their vulnerability to various diseases.

Pharmacists know the rules of the game and cannot convince anyone why they flout them, other than greed for cash even when they put lives on danger.

The Pharmacy and Poisons Board has its job cut out; it must move quickly to rein in errant pharmacists and stop this dangerous practice. Those found flouting the rules must be punished. Pharmacists must be compelled to play by the rules.

Similarly, the board needs to mount an aggressive campaign to educate the public on the perils of self-medication. The list of drugs that can only be given after a doctor’s prescription ought to be circulated widely to stop abuse.

We need stringent rules and effective systems to monitor the operations of pharmacies to eliminate irregular practices that imperil the citizens.

Terre Haute Pharmacist Charged with Health Care Fraud

Terre Haute, Ind.- Joseph H. Hogsett, United States Attorney, announced today that John D. Love, Brazil, Ind., was charged with health care fraud and money laundering following an investigation by the Health and Human Services, Office of Inspector General (HHS), The Internal Revenue Service (IRS), the Federal Bureau of Investigation (FBI), and Indiana Attorney General Greg Zoeller’s Medicaid Fraud Enforcement Unit (MFCU).

The Information alleges that beginning on or about January 1, 2006, and continuing through September 2010, John Love, a pharmacist and controlling member of the Terre Haute Prescription Shop, used his position at the pharmacy to carry out a scheme to defraud the Indiana Medicaid Program.

Love submitted claims to the Indiana Medicaid Program for prescriptions that were never given to patients. Love used his access and knowledge of the THPS computer system to input false prescriptions into the THPS’s computer billing system, which would then bill the Indiana Medicaid Program for the fraudulent claim. As soon as the computer system submitted the claim for the prescription to the Indiana Medicaid Program, Love would access the computer system again and void the prescription before any other employee of THPS could notice a record for a prescription that was never filled or dispensed.

As part of his scheme, the information further alleges Love billed the Indiana Medicaid Program for prescription drugs significantly in excess of what THPS had ever ordered, for example:

*Love billed the Indiana Medicaid Program for 1,317.4 units of the prescription drug Aranesp and received a total of $1,677,554.50. During the same time period, THPS only ordered six units of Aransep at a cost of $5,188.36.
*Love billed the Indiana Medicaid Program for 172 units of the prescription drug Copaxone and received a total of $236,989.54. During the same time period THPS only ordered 20 units of Copaxone at a cost of $29,265.87.

*Love billed the Indiana Medicaid Program for 660 units of the prescription drug Epogen and received a total of $126,732.80. During the same time period, THPS only ordered ten units of Epogen at a cost of $2,545.69.

*Love billed the Indiana Medicaid Program for 588 units of the prescription drug Humira and received a total of $429,959.82. During the same time period, THPS only ordered 98 units of Humira at a cost of $62,693.53.

*Love billed the Indiana Medicaid Program for 1,488 units of the prescription drug Procrit and received a total of $615,612.23. During the same time period, THPS only ordered 22 units of Procrit at a cost of $6,366.40.

*Love billed the Indiana Medicaid Program for 2,630 units of the prescription drug Sandostatin and received a total of $343,334.58. During the same time period, THPS did not order any units of Sandostatin.

As a result of Love’s fraudulent acts, the Indiana Medicaid Program paid THPS $3,575,699.73 for prescriptions that were never provided to patients. These funds were deposited into the main business account of THPS. Using his control of THPS, Love used at least $3,000,000 of the fraudulent proceeds to purchase, in whole or in part, four parcels of real estate; fifteen vehicles, including five Harley Davidson motorcycles, a Chevrolet Corvette, and a Cadillac Escalade; a destination wedding for one of his children in Destin, Florida; and numerous other personal expenses. The money laundering charges concern the purchase of one Harley Davidson motorcycle and the destination wedding.

U.S. Attorney Hogsett stated, “The United States Attorney’s Office will continue to aggressively prosecute Medicaid fraud. Individuals who, through their own greed, take benefits intended to serve the neediest citizens, will be investigated and prosecuted to the fullest extent of the law.”

“Health Care Fraud is a serious problem in Indiana and is vigorously investigated by the Federal Bureau of Investigation and our law enforcement partners. The FBI will continue to use a wide-array of investigative techniques to recover taxpayer dollars and root out those who corrupt the health care system,” said Michael Welch, Special Agent in Charge of the Federal Bureau of Investigation.

“The charges brought today against Mr. Love clearly serve as a warning that federal and state governments are tightly coordinating the investigation and prosecution of Medicaid fraud,” said Lamont Pugh III, Special Agent in Charge of the Chicago Region of the U.S. Department of Health and Human Services, Office of Inspector General. “Criminals who would line their pockets at the expense of tax payers and vulnerable patients can expect both federal and state authorities to be in hot pursuit.”

Al Patton, Special Agent in Charge of the IRS said, “IRS Criminal Investigation has the financial investigators and expertise that is critical in locating the money. We work closely with our partners in law enforcement and our partners at the United States Attorney’s Office to ensure the defendants are brought to justice”.

“For a pharmacist to bill the taxpayers millions of dollars for prescription drugs that doctors never ordered and patients never received is a brazen abuse of the Medicaid system. The Attorney General’s Medicaid Fraud Control Unit collaborates closely with our federal colleagues to unravel such schemes so that those who try to game the system will be held accountable,” Indiana Attorney General Greg Zoeller said.

As part of the investigation, federal authorities seized five Harley Davidson motorcycles, two sports cars (a Corvette and a Mustang), four sport utility vehicles, two pickup trucks, one four-wheeler RV and trailer, and funds from multiple bank accounts. The government will be seeking forfeiture of these and other assets.

According to Assistant U.S. Attorney Bradley P. Shepard, who is prosecuting the case for the government, Love faces a maximum of 10 years in prison and a $250,000 fine. An initial hearing will be scheduled for an initial appearance and arraignment in Terre Haute before a U.S. Magistrate Judge.

An information is only a charge and is not evidence of guilt. A defendant is presumed innocent and is entitled to a fair trial at which the government must prove guilt beyond a reasonable doubt.

Shortlink

Pharmacy News Online: CVS/pharmacy Encourages Consumers to Consult With Pharmacists

CVS/pharmacy Encourages Consumers to Consult With Pharmacists

Nearly half of Americans take at least one prescription drug per month(1), according the Centers for Disease Control and Prevention, yet many do not take advantage of the one healthcare professional who can be the most helpful when it comes to their medications: their pharmacist.

CVS/pharmacy is reminding consumers about the importance of pharmacist consultations and the critical role pharmacists play in managing ongoing medications for chronic illnesses, especially when starting a new medication. In its most recent initiative, CARE 1on1™, CVS/pharmacy offers patients dedicated one-on-one time with a pharmacist to discuss savings, safety and side effects when their prescription is transferred or filled for the first time.

Up to 50 percent of chronically ill people stop taking their medication within the first year. Pharmacists understand many of the contributing factors, which range from cost and side effects to the inherent challenges of taking multiple medications, and can help address them. In fact, CVS Caremark research shows a pharmacist in a face-to-face setting is the most effective healthcare professional at encouraging patients to take medications as prescribed.

“Patients with chronic health issues like asthma, or chronic diseases like diabetes, often take more than one medication – each with its own set of directions and possible side effects,” says Papatya Tankut, R.Ph., Vice President of Pharmacy Professional Services at CVS Caremark. “Our pharmacists are here to help patients get the most out of their medications once they leave the doctor’s office. Taking the time to speak to a pharmacist about your prescriptions can make a difference in the overall improvement of your health, particularly for those who are starting a new prescription.”

Generic viagra canadian pharmacy

When patients spend dedicated time with a CVS pharmacist through CARE 1on1™, they will receive a personal review of their new ongoing medication filled at CVS/pharmacy and discuss ways to manage side effects, save money and stick to a medication routine.

CVS/pharmacy offers the following tips for new prescriptions:
Plan your medication schedule: If you are taking more than one medication, ask the pharmacist which ones can be taken together or need to be taken separately.
Make medications part of your daily routine: Take your medications at the same time you do something else every day.
Use organization tools: Remind yourself to take your medicine by posting a sticky note, setting a watch or timer, using a pill organizer or creating a check-off chart. Your CVS pharmacist can recommend the right tool for you.
Speak with your pharmacist about side effects or a missed dose: Although many medications are well tolerated, you may experience mild side effects when your body adjusts to a new medication. Do not stop taking your medication until you speak with your pharmacist. Call or visit your CVS pharmacist if you miss a dose and are unsure of what to do.

Woman who avoided bloodbath after taking day off mourns sister killed at Long Island pharmacy

The heartbroken sister of a teenage pharmacy worker murdered in a Long Island robbery, broke down in tears Monday as she visited the scene of the crime.

Leslie Mejia – who also works at the Haven Pharmacy in Medford but avoided the tragedy by taking Sunday off – was embraced by her father, Rene, as she unleashed a flood of tears.

“She was a great girl. My sister was a good person. She didn’t deserve to die – not like that,” Mejia said of her 17-year-old sibling, Jennifer, who was one of four victims of Sunday morning’s shooting during a robbery gone bad.

“I know she’s an angel. She’s watching over us,” the 16-year-old added before driving off in an SUV.

DEA agents were later spotted combing through the pharmacy.

Residents of the shaken community mourned Monday while praying that the killer would soon be caught.

“It’s a brazen attack on innocent people. It’s a terrible, terrible tragedy,” said Stephanie Meoli-Lauenborg, 39, as she placed a handful of purple and pink wild flowers outside the shuttered Haven Pharmacy in Medford.

The terrifying daylight attack ended with the gunman fatally shooting store employees Raymond Ferguson, 45, and Mejia, and customers Bryon Sheffield, 71, and Jaime Taccetta, 33.

Police say the suspect then made off with prescription drugs and remains at large.

“I’m disgusted,” Meoli-Lauenborg said, as she cradled her 21-month-old daughter, Giada, in her arms. “We’re walking on eggshells. We have our eyes open now, to everybody, and it’s a shame.”

Nearly 2,400 people have signed an online condolence page for Mejia on Facebook.

“You were an angel on earth Jen,” wrote Roger Naughton.”You truly were. I’m going to miss you so much. This still feels like a nightmare that I can’t wake up from.”

A wake will be held for Mejia on Tuesday and Wednesday from 7 p.m.-9 p.m. in Patchogue at the Robertaccio Funeral Home, according to the tribute page.

Mejia, of East Patchogue, wanted to be a doctor one day, her family said. She had been looking forward to graduating from Bellport High School on Thursday.

She had her prom dress all ready, a blue number with spaghetti straps that she had modeled proudly for her family the night before she died.

Taccetta’s devastated relatives said they were too shaken to talk to reporters.

“It’s a terrible loss. My sister passed away. She got murdered and we need our privacy,” said a brother who wouldn’t give his name. “Our family wants a lot of privacy. We don’t want to talk to anybody.”

Police described the suspect as a thin white man, about 5-feet-8, with short, dark hair. He was wearing a white baseball hat, sunglasses, a dark-colored hooded sweatshirt and blue jeans.

“This is a vicious, horrible crime,” said Suffolk County Police Chief of Detectives Dominick Varrone.

Cops found the bodies after a man called from the store’s parking lot to report gunfire.

Jennifer’s father said she liked working at the pharmacy because she intended to go to medical school.

“With this, we lost a good doctor,” he said.

OXIS International Announces Online Registration Now Available for 2011 Ergothioneine Congress

OXIS International, Inc. (OTC Bulletin Board: OXIS; Euronext Paris: OXI) announces that online registration is now open for the “First International Congress on Ergothioneine, Antioxidants & Age Management Medicine” being held Friday, July 15 through Sunday, July 17 at the DeNeve Auditorium on the campus of the University of California Los Angeles.

The Congress is being hosted by the Gerontology Research Group and OXIS International is the major sponsor. This is the first conference ever held on this important subject and will focus on Ergothioneine’s mechanisms of action, health benefits and safety profile, along with potential new applications. More than two dozen presentations will be made by leading researchers and clinicians in the fields of nutrition, age management and oxidative stress. The world-class faculty includes Dr. Penny Kris-Etherton, Esteemed Professor of Nutrition at Pennsylvania State University; Dr. John Repine, Director of the Webb-Waring Institute at the University of Colorado; Dr. Okezie Aruoma, founding faculty member of the Tuoro School of Pharmacy; Dr. L. Steven Coles, Executive Director of the Gerontology Research Group; and Dr. Bruce N. Ames, Professor of Biochemistry and Molecular Biology, University of California Berkeley, and a Senior Scientist at Children’s Hospital Oakland Research Institute.

“OXIS International is proud to be a major sponsor of this First International Congress on Ergothioneine,” said Bernie Landes, President of OXIS International. “The Congress has a tremendous lineup of speakers, including keynote presentations by Dr. Stephen Clarke, Director of the Molecular Biology Institute at UCLA and Dr. Alexander Schauss, CEO and Senior Director of Natural and Medicinal Products Research at AIBMR Life Sciences. The complete presentation agenda offers unique value to healthcare professionals, wellness advocates, pharmaceutical scientists, physicians and pharmacists, food scientists and technologists interested in the role of antioxidants in the maintenance of optimal health throughout the natural aging process.”

Accreditation

Antioxidants and Age Management Medicine: First International Congress on Ergothioneine, with a beginning date of July 15, 2011, has been reviewed and is acceptable for up to 13.75 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award.

About Ergothioneine

Leading members of the scientific community believe that L-ergothioneine (Ergothioneine) may ultimately be shown to be one of the most powerful and effective antioxidants ever discovered, with numerous applications ranging from the maintenance of vibrant good health to the provision of unique nutritional support in the management of inflammation and oxidative stress, as well as providing profound benefits in skin care formulations. There is continued interest in the use of nutraceutical compounds such as Ergothioneine to support heart health, brain health and immune function, to support healthy aging, protect and enhance the skin, support joint health and vision and provide an enhanced foundation for overall health and wellness. The full range of basic and applied science related to the role of Ergothioneine will be discussed at the Congress.

How Technology is Being Used in New Ways to Sort through the Clutter and Discover Hidden Deals on Prescription Drugs at Retail Pharmacies in your ZIP code

Finding an affordable price on prescription medication has historically been a frustrating experience. This has driven many to unlicensed ‘pharmacies’ in Canada, Mexico and elsewhere and is a risk to public safety. One startup is making it much easier to find and take advantage of surprisingly good deals at retail pharmacies in the U.S. When a customer selects a deal online, a confirmation prints out at the pharmacy and the price is guaranteed.

Dallas, TX (PRWEB) June 20, 2011

Pharmacy customers nationwide can now take advantage of a system called Zip-Price that progressively searches discounted prescription prices at neighborhood retail pharmacies. One of a suite of innovative pharmacy help features available online through technology startup ZipcodeMeds™, the Zip-Price process is optimized to rapidly conduct a robust multi-pronged price search that examines both published discount lists and unpublished secondary deals. In addition, Zip-Price allows the generation of a customized price request that pops up on the screens at multiple pharmacies to spur competitive price quotes. The customer can choose the best one to lock-in online before even stepping foot in the pharmacy. Regardless of the method that the process uses to yield an eventual price, the goal is for that price to be the best possible on that day, in that area and one that the customer can take immediate action on if so desired.

To use Zip-Price, customers simply enter their 5 digit location ZIP code and any medication for which they have a legal prescription. No account is needed to begin the search. Andy Keesler, a member of the Zip-Price development team says “Unlike other pricing solutions, we modeled Zip-Price after the type of process that pharmacy insiders would follow if they had to look for a discount price for themselves. A key insight was that using a single approach rarely produces great results so we designed our system for each request to automatically trigger multiple methods of price search.” From the customer’s single request, the system first scours databases of discount programs at area pharmacies to see if the medication is steeply discounted anywhere. Bayo Adeniyi, a member of the customer and provider insights team explains “These lists are different from one another and are always changing. Wal-Mart pioneered the extremely successful $4 generic program but many people don’t realize that, depending on the medications they take, another pharmacy might have a superior program. In one 5 mile radius in Dallas, TX for example, the market rate for 30 tablets of a long term cholesterol medication like Simvastatin 20mg (generic for Zocor) is $16.84 at Wal-Mart, $37.99 at CVS, and $59.99 at Walgreens. Savon pharmacy in the same 5 mile radius offers the exact same medication for $4.99 if purchased via their $10 lifetime Rxtra savings program and Walgreens’ price just recently dropped to $12.99 if the customer uses their $20 per annum prescription savings club discount program. With the continuous changes in these lists and because of the many companies that now offer one, keeping up with current best pricing on any medication can be an ordeal. By using ZipcodeMeds™, customers will find the best prices available on these programs within 10 seconds.”

If the system does not find a price in the discount program search, it automatically routes the request to the secondary deals pathway where it searches for short-term deals or any listed prices from local pharmacies that stand out for being a significantly good deal. Keesler continues “To ensure that customers have a very high chance of finding a deal, the system automatically routes unsatisfactory pricing results to our unique Zip-Bid pathway. With one-click the customer can generate a personalized on-demand price bid request that instantly pops up on the screen at multiple local pharmacies. Pharmacies evaluate the request quickly and respond with an exact quote that expires by a set time. Customers can select the best bid and lock-in the price online. It’s simple for the customer and convenient for the pharmacy.”

ZipcodeMeds™ recommends the use of manufacturer coupons when available as this could potentially mean getting an expensive medication for free. “Our work on pricing includes a process to inform customers when coupons may be available either from their physician, direct from the manufacturer or online. We also encourage customers to keep using whatever discount card or other non-insurance program that they already use but to never assume that they are paying the lowest price until they compare to the comprehensive results they get on ZipcodeMeds” said an analyst on the team. “The so-called discount cards can be misleading. Many discount cards offer a price of about $19 on 30 tablets of the generic for Bactrim DS (a commonly prescribed antibiotic) when the same drug is only about $4 at many pharmacies that we feature on our website. Even on drugstore.com, a reputable online pharmacy, the lowest price available for 30 tablets of generic Bactrim DS (as of June 2011) is about $19. Using a discount card or online pharmacy in this scenario means you spend almost 400% more but get the false impression that you got a great deal. Spending a few seconds on our site is like putting in hours of quality work verifying that you’re paying a competitive price. What you do after that is up to you but it should be pretty easy to make a smart decision afterwards because numbers simply do not lie.”

Earnings Preview: Walgreen

Walgreen Co. (WAG – Analyst Report) is scheduled to release its third quarter 2011 earnings on Tuesday, June 22, 2011, before the market opens.

The Zacks Consensus Estimate for the third quarter is pegged at 62 cents per share.

The company has already reported total sales of $18.38 billion in the third quarter, up 6.8% from $17.20 billion in the year-ago period. Comparable store sales (those open for more than a year) increased 4.1% during the quarter, while front-end comparable store sales also spiked 3.9%, with prescriptions filled at comparable stores increasing by 4.2%.

Previous Quarter Highlights

Walgreen reported EPS of 80 cents in the fiscal second quarter, in line with the Zacks Consensus Estimate but higher than the year-ago earnings of 68 cents. The prior year’s EPS included restructuring cost and integration costs of a penny each associated with the Duane Reade acquisition.

Net sales for the quarter increased 8.9% year over year to $18.5 billion. While comparable store sales during the quarter increased 4.1%, front-end comparable drugstore sales jumped 4.3%. Prescription sales, accounting for 62.6% of sales in the quarter, leaped 7.7%, while prescription sales in comparable stores increased by 3.9%. Moreover, the company also raised its retail pharmacy market share to 20.1%.

Agreement of analysts

Estimate revision trends among analysts depict a positive bias for the company’s earnings in the third quarter. Over the last 30 days, out of the 20 analysts covering the stock, estimates have been raised by 4 analysts with none moving in the opposite direction.

However, estimate revisions for fiscal 2011 reflect a negative bias. Over the last 30 days, out of the 8 analysts covering the stock, 3 have downgraded estimates for the quarter while none raised their estimates.

Earlier this month, Walgreen completed the divestment of its pharmacy benefit management (PBM) business to Catalyst Health Solutions (CHSI – Analyst Report) for $525 million in cash. Subsequent to this deal, Walgreen will be able to better focus on its 7,700 drug stores.

We are also awaiting more update regarding sales trends, Walgreen’s Customer-Centric Retailing (CCR) initiative and the progress on the Rewiring initiative. At the end of the second quarter, the company converted 1,873 stores and opened 450 new stores with the CCR format.

Walgreen expects to convert 3,200 stores and open approximately 100 new stores with the CCR format by the end of 2011. For the remaining remodels, the company expects to incur costs of approximately $45,000 per store.

Moreover, in order to accelerate its Infusion Pharmacy business, Walgreen decided to limit its presence in the respiratory therapy durable medical equipment (RTDME). In December, the company started the process of selling facilities and currently has sold RTDME operations in six states.

In June 2011, Walgreen completed the acquisition of online retailer drugstore.com for a total enterprise value of $409 million. Walgreen plans to reinvest in this business and expects the transaction to be dilutive by 3 cents per share to fourth quarter of fiscal 2011 earnings.

Surprise

Analyzing past trends, Walgreen has exceeded estimates in two of the last four quarters and missed in one. However, the company has an average surprise of 2.88% over the trailing four quarters.

Our Recommendation

We are encouraged by Walgreen’s strategic decisions, including the sale of the PBM business and the acquisition of drugstore.com. Moreover, the company has made satisfactory progress with respect to the CCR rollout and meeting the targeted savings under the rewiring initiative. The benefits from these initiatives will be experienced over a period of time.

In order to make the best use of available funds, Walgreen has scaled down its stores opening target. We believe this decision will benefit the company as the new stores take 2 to 3 years to break even. Leveraging on its strong cash balance, the company is well equipped to pursue suitable acquisitions in future.

However, Walgreen has been impacted by high unemployment levels and lower discretionary spending in the past few quarters.

How The Immune System Holds Off Against Anthrax

Scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered how the body”s immune system launches its survival response to the notorious and deadly bacterium anthrax. The findings, reported online today and published in the June 22 issue of the journal Immunity, describe key emergency signals the body sends out when challenged by a life-threatening Exposure to anthrax often proves deadly. The anthrax bacterium can invade immune cells called macrophages and release potent toxins that paralyze key biochemical pathways, causing rapid cell death. Unchecked, the process may completely collapse the body”s immune defenses, allowing the bacteria to proliferate, and ultimately lead to septic shock and high mortality.

The researchers discovered that the fight against invading anthrax bacteria begins with the first infected cell. They found that initially impacted macrophages immediately communicate with other immune cells to sound the alarm and develop a survival strategy. Remarkably, the key signaling molecule involved in the survival response is adenosine triphosphate or ATP, a basic currency of energy transfer used by all organisms.

“The warning alarm sounded during anthrax infection is elegant, complex and can be effective in slowing spread of the pathogen,” said Michael Karin, PhD, distinguished professor of pharmacology and senior author of the study.

Karin explained that ATP is released from macrophages infected and poisoned with anthrax toxins through a special channel in the cell membrane. This ATP is then sensed by a receptor on a second macrophage, which assembles and activates a complex of molecules known as the inflammasome. The inflammasome then releases into the bloodstream an immune-activating molecule known as interleukin-1beta (IL-1beta), which alerts macrophages throughout the body to mobilize and increase their resistance to anthrax-induced cell death.